The COMPASSION Study is looking at how telehealth check-ins can improve the in-home hospice experience for people with unresectable (cannot be removed by surgery) locally advanced or metastatic (spread to other parts of the body) breast cancer. This study uses "Telehealth Hospice Visits," which are check-in appointments with your oncology (cancer) care team, including doctors, physician assistants, nurse practitioners, or hospice nurses, using video calls (like Zoom) or phone calls. The main goal is to see how many participants complete these telehealth check-ins within four weeks. You may be able to join if you are 18 or older, have unresectable locally advanced or metastatic breast cancer, are eligible for in-home hospice services, and can do video or phone check-ins. The study status is currently unclear.

Study design

This is an interventional study planning to include about 200 people, which includes 50 participants, 50 caregivers, 50 hospice nurses, and 50 oncology providers.

What's involved

You would give verbal consent and complete a one-time survey by email or phone call. You would also participate in telehealth check-in appointments with your oncology care team.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint is measured at up to 4 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.